Rapid Evolution of Reduced Susceptibility against a Balanced Dual-Targeting Antibiotic through Stepping-Stone Mutations
Authors:
- 1 September 2019
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 63 (9)
Abstract
Multitargeting antibiotics, i.e., single compounds capable of inhibiting two or more bacterial targets, are generally considered to be a promising therapeutic strategy against resistance evolution. The rationale for this theory is that multitargeting antibiotics demand the simultaneous acquisition of multiple mutations at their respective target genes to achieve significant resistance. The theory presumes that individual mutations provide little or no benefit to the bacterial host.Keywords
All Related Versions
This publication has 77 references indexed in Scilit:
- RNA-guided editing of bacterial genomes using CRISPR-Cas systemsNature Biotechnology, 2013
- Restoring Methicillin-Resistant Staphylococcus aureus Susceptibility to β-Lactam AntibioticsScience Translational Medicine, 2012
- VarScan 2: Somatic mutation and copy number alteration discovery in cancer by exome sequencingGenome Research, 2012
- Beyond serial passages: new methods for predicting the emergence of resistance to novel antibioticsCurrent Opinion in Pharmacology, 2011
- Exploiting bacterial DNA gyrase as a drug target: current state and perspectivesApplied Microbiology and Biotechnology, 2011
- Interplay in the Selection of Fluoroquinolone Resistance and Bacterial FitnessPLOS Pathogens, 2009
- Fast and accurate short read alignment with Burrows–Wheeler transformBioinformatics, 2009
- Bactericidal Activities of Meropenem and Ertapenem against Extended-Spectrum-β-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae in a Neutropenic Mouse Thigh ModelAntimicrobial Agents and Chemotherapy, 2007
- Basic Local Alignment Search ToolJournal of Molecular Biology, 1990
- Basic local alignment search toolJournal of Molecular Biology, 1990